Recent progress and applications in glycosaminoglycan and heparin research

Tatiana Nikolaevna Laremore, Fuming Zhang, Jonathan S. Dordick, Jian Liu, Robert J. Linhardt

Research output: Contribution to journalReview article

78 Citations (Scopus)

Abstract

Heparin, the focus of this review, is a crucially important anticoagulant drug produced from animal sources, which was contaminated last year leading to a number of adverse side effects, some resulting in death. Heparin is a highly acidic polysaccharide and a member of a family of biopolymers called glycosaminoglycans. The structure and activities of heparin are detailed along with recent advances in heparin structural analysis and biological evaluation. Current state-of-the-art chemical and chemoenzymatic synthesis of heparin and new approaches for its metabolic engineering are described. New technologies, including microarrays and digital microfluidics, are proposed for high-throughput synthesis and screening of heparin and for the fabrication of an artificial Golgi.

Original languageEnglish (US)
Pages (from-to)633-640
Number of pages8
JournalCurrent Opinion in Chemical Biology
Volume13
Issue number5-6
DOIs
StatePublished - Dec 1 2009

Fingerprint

Glycosaminoglycans
Heparin
Research
Digital microfluidics
Metabolic engineering
Metabolic Engineering
Biopolymers
Microfluidics
Microarrays
Structural analysis
Anticoagulants
Polysaccharides
Screening
Animals
Throughput
Technology
Fabrication

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Analytical Chemistry

Cite this

Laremore, Tatiana Nikolaevna ; Zhang, Fuming ; Dordick, Jonathan S. ; Liu, Jian ; Linhardt, Robert J. / Recent progress and applications in glycosaminoglycan and heparin research. In: Current Opinion in Chemical Biology. 2009 ; Vol. 13, No. 5-6. pp. 633-640.
@article{1aa73d9bf83a42e7b6b26dd494131340,
title = "Recent progress and applications in glycosaminoglycan and heparin research",
abstract = "Heparin, the focus of this review, is a crucially important anticoagulant drug produced from animal sources, which was contaminated last year leading to a number of adverse side effects, some resulting in death. Heparin is a highly acidic polysaccharide and a member of a family of biopolymers called glycosaminoglycans. The structure and activities of heparin are detailed along with recent advances in heparin structural analysis and biological evaluation. Current state-of-the-art chemical and chemoenzymatic synthesis of heparin and new approaches for its metabolic engineering are described. New technologies, including microarrays and digital microfluidics, are proposed for high-throughput synthesis and screening of heparin and for the fabrication of an artificial Golgi.",
author = "Laremore, {Tatiana Nikolaevna} and Fuming Zhang and Dordick, {Jonathan S.} and Jian Liu and Linhardt, {Robert J.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1016/j.cbpa.2009.08.017",
language = "English (US)",
volume = "13",
pages = "633--640",
journal = "Current Opinion in Chemical Biology",
issn = "1367-5931",
publisher = "Elsevier Limited",
number = "5-6",

}

Recent progress and applications in glycosaminoglycan and heparin research. / Laremore, Tatiana Nikolaevna; Zhang, Fuming; Dordick, Jonathan S.; Liu, Jian; Linhardt, Robert J.

In: Current Opinion in Chemical Biology, Vol. 13, No. 5-6, 01.12.2009, p. 633-640.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Recent progress and applications in glycosaminoglycan and heparin research

AU - Laremore, Tatiana Nikolaevna

AU - Zhang, Fuming

AU - Dordick, Jonathan S.

AU - Liu, Jian

AU - Linhardt, Robert J.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Heparin, the focus of this review, is a crucially important anticoagulant drug produced from animal sources, which was contaminated last year leading to a number of adverse side effects, some resulting in death. Heparin is a highly acidic polysaccharide and a member of a family of biopolymers called glycosaminoglycans. The structure and activities of heparin are detailed along with recent advances in heparin structural analysis and biological evaluation. Current state-of-the-art chemical and chemoenzymatic synthesis of heparin and new approaches for its metabolic engineering are described. New technologies, including microarrays and digital microfluidics, are proposed for high-throughput synthesis and screening of heparin and for the fabrication of an artificial Golgi.

AB - Heparin, the focus of this review, is a crucially important anticoagulant drug produced from animal sources, which was contaminated last year leading to a number of adverse side effects, some resulting in death. Heparin is a highly acidic polysaccharide and a member of a family of biopolymers called glycosaminoglycans. The structure and activities of heparin are detailed along with recent advances in heparin structural analysis and biological evaluation. Current state-of-the-art chemical and chemoenzymatic synthesis of heparin and new approaches for its metabolic engineering are described. New technologies, including microarrays and digital microfluidics, are proposed for high-throughput synthesis and screening of heparin and for the fabrication of an artificial Golgi.

UR - http://www.scopus.com/inward/record.url?scp=70549101182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70549101182&partnerID=8YFLogxK

U2 - 10.1016/j.cbpa.2009.08.017

DO - 10.1016/j.cbpa.2009.08.017

M3 - Review article

VL - 13

SP - 633

EP - 640

JO - Current Opinion in Chemical Biology

JF - Current Opinion in Chemical Biology

SN - 1367-5931

IS - 5-6

ER -